Surgical Castration in Hormone-Refractory Metastatic Prostate Cancer Patients Can Be an Alternative for Medical Castration

Background. Most patients with metastatic prostate cancer are endocrinologically treated with LHRH agonist, but finally castration-refractory and hormone-refractory cancers occur. Serum testosterone levels get low to “the castration level” by LHRH agonists but may not get low enough against castrati...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zaitsu, Masayoshi, Yamanoi, Mariko, Mikami, Koji, Takeshima, Yuta, Okamoto, Naohiko, Imao, Sadao, Tonooka, Akiko, Takeuchi, Takumi
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2012
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3130489/
https://ncbi.nlm.nih.gov/pubmed/21754927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/979154
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars